SEATTLE, WA – Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that Jonathan Drachman, M.D., Chief Executive Officer,… Read More
VANCOUVER, BC – Sonic Incytes Medical Corp. is pleased to present its breakthrough liver health assessment solution, VelacurTM, at the Digital Medicine & Medtech Showcase 2021, part of Biotech Showcase™… Read More
Global coalition for adaptivev research, Kazia and Kintara announce commencement of Kazia’s Paxalisib and Kintara’s VAL-083 in GBM agile trial Kazia and Kintara now enrolling in GBM agile, registrational phase… Read More
VANCOUVER, BC – Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, is pleased to announce that it is one of only four companies selected to receive advisory services and research and… Read More
VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ:INM) (TSX:IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development… Read More
